Table 3.
Pharmacokinetics and Pharmacodynamics of OTC Cough and Cold Drug Components in Pediatrics
Drugs | Pharmacokinetics Process | Pharmacokinetic Parameters | Pharmacodynamics | References | |
---|---|---|---|---|---|
Acetaminophen | Absorption | Bioavailability | ~72% | The analgesic effects are thought to be brought on by the activation of descending serotonergic inhibitory pathways in the CNS, while the antipyretic effects result from the inhibition of the hypothalamus heat-regulating center | [51–54] |
pKa | 9.38 | ||||
Distribution | Volume distribution | 0.85–1.5 L/kg | |||
Protein binding | 10–30% | ||||
Metabolism | - | Metabolized in the liver to sulfate and glucuronide conjugates. | |||
Excretion | T ½ | 2.6–2.8 hours | |||
Clearance | 400 mL/minute | ||||
Pseudoephedrine | Absorption | Bioavailability | N/A | It directly stimulates beta-adrenergic receptors, while indirectly it activates alpha-adrenergic receptors, triggering the release of endogenous norepinephrine from neuronal granules | [55–57] |
pKa | 10.25 | ||||
Distribution | Volume distribution | ~2.5 L/kg | |||
Protein binding | 20% | ||||
Metabolism | Metabolized in the liver to produce active nor-pseudoephedrine (<1%). | ||||
Excretion | T ½ | ~3 hours | |||
Clearance | 7.3–7.6 mL/minute/kg | ||||
Dextromethorphan | Absorption | Bioavailability | 11% | It works by reducing the sensitivity of cough receptors and preventing the transmission of cough impulses by suppressing the medullary cough center through the activation of sigma receptors | [51,58–60] |
pKa | 9.8 | ||||
Distribution | Volume distribution | 5.0–6.7 L/kg | |||
Protein binding | 60–70% | ||||
Metabolism | - | Metabolized in the liver to dextrorphan (active) and lower quantities of 3-hydroxy and 3-methoxy derivatives. | |||
Excretion | T ½ | 4.9–6.41 hours | |||
Clearance | 33.8 mL/minute/ kg | ||||
CTM | Absorption | Bioavailability | 59% | It is competing with histamine for H1-receptor sites on effector cells in the respiratory system, gastrointestinal tract, and blood vessels | [61–64] |
pKa | 9.2 | ||||
Distribution | Volume distribution | 7 L/kg | |||
Protein binding | 29–37% | ||||
Metabolism | Metabolized in the liver to active and inactive metabolites. | ||||
Excretion | T ½ | 13.1 hours | |||
Clearance | N/A | ||||
Abbreviations: CTM, chlor-trimeton or chlorpheniramine maleate; pKa is the acid dissociation constant; T½, half-life of a drug; CNS, central nervous system; N/A, not available.